4//SEC Filing
Millar Kerri-Ann 4
Accession 0001209191-22-047161
CIK 0001645460other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:03 PM ET
Size
8.8 KB
Accession
0001209191-22-047161
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2022-08-22$3.05/sh−2,828$8,625→ 14,311 total - Exercise/Conversion
Common Stock
2022-08-21+6,667→ 17,139 total - Exercise/Conversion
Restricted Stock Units
2022-08-21−6,667→ 0 total→ Common Stock (6,667 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739126
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:03 PM ET
- Size
- 8.8 KB